LEXINGTON, Ky. (Jan. 28, 2022) – Heart disease is the leading cause of death among women in the United States. More than 4,800 women die each year from heart disease in Kentucky.
Esteemed NIH Award Will Support UK Scientist’s Work in Improving Women’s Health
Since he was a graduate student, Patrick Hannon, PhD, has had his eyes set on a prestigious National Institutes of Health (NIH) grant that he knew, if he received it, would enable him to make a tremendous impact in his career goal of advancing reproductive care for women.
Dr. Hannon, now an assistant professor in the UK College of Medicine Department of Obstetrics and Gynecology, was elated to find out that this winter, he achieved his longtime goal.
'Think Big, Then Think Bigger': How Dr. Gerhardt Conducts Innovative Neuroscience Research at UK
Greg Gerhardt, PhD, is a professor of neuroscience and researcher with the Spinal Cord and Brain Injury Research Center (SCoBIRC) and Brain Restoration Center, as well as advisor for the MD/PhD program. He currently serves as co-principal investigator for the Brain Restoration Alliance in Neurodegeneration (BRAIN). In the following Q&A, Dr. Gerhardt shares more about his current projects.
Q: Why did you want to pursue a career in neuroscience research?
Healthy Hearts for Women - Feb. 4, 2022
|
Annual Symposium Explores Advancements in Women's Heart Health
Behind the Blue: UK Alum & Current Miss USA Elle Smith Discusses Cervical Cancer Prevention and Education
LEXINGTON, Ky. (Jan. 28, 2022) — When University of Kentucky alum Elle Smith was crowned Miss USA in November, her life changed in an instant.
With her name catapulted into the national spotlight, Smith quickly learned the power of the Miss USA title and platform, and the importance of capitalizing on every open door.
During her year of reign as Miss USA, Smith will work with the National Cervical Cancer Coalition to educate women about cervical cancer prevention and treatment in an effort to empower women to seek preventative care.
KYNETIC Seeks Applications for Proof-of-concept Commercialization
LEXINGTON, Ky. (Jan. 27, 2022) — The Kentucky Network for Innovation and Commercialization (KYNETIC) has opened its Spring 2022 Cycle 5 round of early-stage commercialization grants.
KYNETIC is a National Institutes of Health (NIH) funded Research Evaluation and Commercialization Hub (REACH) and part of the national NIH Proof-of-Concept Network.
‘Right Place at the Right Time’: UK Medical Student’s Journey to Health Care Career Started as a Patient
Anna Cox was a couple of years out of college in 2018, a mathematical economics graduate from the University of Kentucky who had just landed a job as a logistics broker, when a moment of tear-inducing pain sent her to the emergency room.
UK HealthCare physicians and staff delivered her with some alarming news – her pain might be caused by cancer.
“Wait, I’m never sick,” Cox thought in disbelief. She was 23 years old without any known health issues and the whole world ahead of her. She didn’t even have a primary care physician. Quite frankly, she didn’t know what to do next.
Congratulations Taylor Valentino, PhD
On Thursday, January 20, 2022 Taylor Valentino successfully defended his dissertation and earned his doctoral degree. Congratulations, Dr. Valentino!
WATCH: UK Experts Answer Latest Questions About COVID-19 Vaccines, Omicron
LEXINGTON, Ky. (Jan. 20, 2022) — As the University of Kentucky begins another semester during the COVID-19 pandemic, experts from across campus are being called upon to answer the many questions being asked by those on campus and in our communities.
RPTA: An Alliance Aiming to Make UK 'Center of the Universe' for Innovative Cancer Treatment
One of the newest research teams within the University of Kentucky’s Alliance Research Initiative wants to make UK “the center of the universe” when it comes to an innovative cancer treatment.
Charles Kunos MD, PhD, director of the Markey Cancer Center Clinical Research Office, leads the Radiopharmaceutical Therapy Alliance (RPTA) with Lowell Anthony, MD, division chief of medical oncology. Alongside faculty and trainees from across the University, they are trying to improve pharmaceutical delivery for patients with cancer through radiopharmaceuticals.
